María del Mar Blanes Martínez is a Consultant Dermatologist at the Department of Dermatology, Dr. Balmis University General Hospital of Alicante, and a Researcher at the Alicante Institute for Health and Biomedical Research (ISABIAL), where she is part of the Medical–Surgical Dermatology Group. She has authored more than 80 scientific articles in national and international journals and has presented over 140 communications and lectures at scientific meetings of national and international scope.
Her Doctoral Thesis, “Cutaneous pathology in HIV-infected patients in Alicante during the era of highly active antiretroviral therapy”, received the Extraordinary Doctorate Award. She has supervised six Master’s Dissertations and is currently co-supervising a Doctoral Thesis.
In the field of teaching, she has served as a clinical tutor for undergraduate students of Medicine and Podiatry at the Miguel Hernández University since 2014, and she also teaches at the Valencian School of Health Studies (EVES). Since 2024, she has been a teaching tutor for dermatology residents, and since 2025, a member of the Teaching Committee of the Dr. Balmis University General Hospital of Alicante.
Her clinical and research activity focuses on autoimmune dermatologic diseases, cutaneous oncology, and dermatologic surgery, with special dedication to the cutaneous lymphoma clinic, which she has led since 2013. She has coordinated and participated in ISABIAL research projects on mastocytosis, calciphylaxis, immune-related toxicities, and cutaneous infections, and serves as local principal investigator in multicenter clinical trials.
She has been a member of the Spanish Cutaneous Lymphoma Group (GELC) of the AEDV since 2013 and has participated in the Spanish National Cutaneous Lymphoma Registry since 2016. She also belongs to the Spanish Group of Autoimmune and Systemic Diseases (GEDEAS) since 2023 and the Spanish Group of Professors and Teachers of Dermatology (GEPDD) since 2025.
In the editorial field, she has been a member of the Editorial Board of Actas Dermosifiliográficas since 2008 and a regular scientific reviewer for this and other dermatology journals. Her teaching, research, and clinical coordination work has been recognized with several awards at scientific meetings of the Spanish Academy of Dermatology and Venereology (AEDV) and its Valencian Section.
Her current lines of work focus on the clinical and translational integration of autoimmune and lymphoproliferative skin diseases, the development of multidisciplinary clinical care protocols, and the undergraduate and specialist training in Dermatology.
María del Mar Blanes Martínez is a Consultant Dermatologist at the Department of Dermatology, Dr. Balmis University General Hospital of Alicante, and a Researcher at the Alicante Institute for Health and Biomedical Research (ISABIAL), where she is part of the Medical–Surgical Dermatology Group. She has authored more than 80 scientific articles in national and international journals and has presented over 140 communications and lectures at scientific meetings of national and international scope.
Her Doctoral Thesis, “Cutaneous pathology in HIV-infected patients in Alicante during the era of highly active antiretroviral therapy”, received the Extraordinary Doctorate Award. She has supervised six Master’s Dissertations and is currently co-supervising a Doctoral Thesis.
In the field of teaching, she has served as a clinical tutor for undergraduate students of Medicine and Podiatry at the Miguel Hernández University since 2014, and she also teaches at the Valencian School of Health Studies (EVES). Since 2024, she has been a teaching tutor for dermatology residents, and since 2025, a member of the Teaching Committee of the Dr. Balmis University General Hospital of Alicante.
Her clinical and research activity focuses on autoimmune dermatologic diseases, cutaneous oncology, and dermatologic surgery, with special dedication to the cutaneous lymphoma clinic, which she has led since 2013. She has coordinated and participated in ISABIAL research projects on mastocytosis, calciphylaxis, immune-related toxicities, and cutaneous infections, and serves as local principal investigator in multicenter clinical trials.
She has been a member of the Spanish Cutaneous Lymphoma Group (GELC) of the AEDV since 2013 and has participated in the Spanish National Cutaneous Lymphoma Registry since 2016. She also belongs to the Spanish Group of Autoimmune and Systemic Diseases (GEDEAS) since 2023 and the Spanish Group of Professors and Teachers of Dermatology (GEPDD) since 2025.
In the editorial field, she has been a member of the Editorial Board of Actas Dermosifiliográficas since 2008 and a regular scientific reviewer for this and other dermatology journals. Her teaching, research, and clinical coordination work has been recognized with several awards at scientific meetings of the Spanish Academy of Dermatology and Venereology (AEDV) and its Valencian Section.
Her current lines of work focus on the clinical and translational integration of autoimmune and lymphoproliferative skin diseases, the development of multidisciplinary clinical care protocols, and the undergraduate and specialist training in Dermatology.